Aurora Spine Corp.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Trent J. Northcutt
- Full Time Employees
- 13
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 20 Holly Street Toronto ON Canada M4S 3B1
- IPO Date
- Aug 27, 2013
- Website
- aurora-spine.com
- Similar Companies
- Business
- Aurora Spine Corporation (TSXV:ASG), through its subsidiary Aurora Spine Inc., develops, manufactures and distributes minimally invasive spinal implants, surgical tools, biologics and interventional pain solutions targeting degenerative disc disease, spinal fusion and sacroiliac joint dysfunction; its core products include interspinous process lumbar fusion devices such as ZIP, ZIP ULTRA, ZIP LP and ZIP-51, Ti-Coated polyether ether ketone interbody cages, sterile-packed titanium plasma spray coated spinal fusion implants, lumbar interbody products including EOS, VOX, Echo, Echo SD and EchoXL, cervical products such as Discovery, anterior lumbar interbody fusion devices like SOLO, posterior sacroiliac fusion systems including SiLO, non-fusion interspinous implants such as Zip Flex, surgical tools encompassing anterior and posterior disc prep systems and Compass 4D Retractor System, and biologics comprising ZIP Graft, Amniopur, TURBO FUSE Fiber Putty, OSTEO GRAFT DBM Putty and OSTEO BRIDGE Sponge Strips. The company, founded in 2012 and headquartered at 20 Holly Street, Suite 300 in Toronto, Ontario, Canada, with design, development and manufacturing operations based in Carlsbad, California, primarily serves orthopedic surgeons, neurosurgeons and pain management specialists worldwide through a focus on patient-centric, regenerative technologies for cervical, thoracolumbar and SI joint applications. In October 2025, Aurora Spine launched Aurora Biologics, a new division offering comprehensive allograft solutions to enhance spinal fusion outcomes and integrate with existing portfolios including ZIP, Hydra A.E.R.O., DEXA and SiLO systems, positioning the company as a vertically integrated provider; earlier in 2025, it secured FDA 510(k) clearance for the Aero facet fusion system, completed enrollment in the Refine study for lumbar interlaminar fusion, and appointed Matt Paxton as executive vice president of sales and Katelyn Sims as area vice president of commercialization and key accounts.
Company News
Aurora Spine Corporation Announces Amendment to Loan from Insider
Aurora Spine Corporation Announces Second Quarter FY26 Financial Results
Aurora Spine Announces Settlement of Arbitration, New Patent License Agreement for SI Joint Product and Increase in Funding from Insider
Aurora Spine and CornerLoc Announce Strategic Commercial Alliance to Expand Minimally Invasive Spine and SI Joint Solutions Nationwide
Aurora Spine Grants Stock Options
Aurora Spine Corporation (ASG:CA) Q1 2026 Earnings Call Transcript
Aurora Spine Corporation Announces First Quarter FY26 Financial Results
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
Aurora Spine Corporation Schedules Release of First Quarter Fiscal 2026 Financial Results
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants
Aurora Spine Corporation (ASG:CA) Q4 2025 Earnings Call Transcript
Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal 2025 Financial Results
Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference
AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER
Aurora Spine Announces Issuance of Two U.S. Patents
Aurora Spine Corporation (ASG:CA) Q3 2025 Earnings Call Transcript
Aurora Spine Corporation Announces Record Third Quarter Financial Results
Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting